Akari Therapeutics (AKTX) announced the appointment of Kameel Farag as its Interim Chief Financial Officer who joined Akari last month. Farag joins Akari after having most recently served as Chief Financial Officer and head of business operations at Aspen Neuroscience
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on AKTX: